{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:27:29Z","timestamp":1788283649291,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.yebeh.2020.107068","type":"journal-article","created":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T16:23:53Z","timestamp":1588523033000},"page":"107068","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Valproate and folate: Congenital and developmental risks"],"prefix":"10.1016","volume":"108","author":[{"given":"Edward H.","family":"Reynolds","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Issue 11","key":"10.1016\/j.yebeh.2020.107068_bb0005","article-title":"Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child","author":"Weston","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.yebeh.2020.107068_bb0010","doi-asserted-by":"crossref","first-page":"k1609","DOI":"10.1136\/bmj.k1609","article-title":"Dangers of valproate in pregnancy","volume":"361","author":"Wieck","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.yebeh.2020.107068_bb0015","doi-asserted-by":"crossref","first-page":"k1596","DOI":"10.1136\/bmj.k1596","article-title":"Weighing the risks in women who could become pregnant","volume":"361","author":"Angus-Leppan","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.yebeh.2020.107068_bb0020","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa0803531","article-title":"Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs","volume":"360","author":"Meador","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2020.107068_bb0025","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1474-4422(12)70323-X","article-title":"Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study","volume":"12","author":"Meador","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2020.107068_bb0030","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1212\/01.wnl.0000339399.64213.1a","article-title":"Autism spectrum disorders following in utero exposure to antiepileptic drugs","volume":"71","author":"Bromley","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2020.107068_bb0035","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.yebeh.2013.08.001","article-title":"Fetal antiepileptic drug exposure: adaptive and emotional\/behavioural functioning at age 6 years","volume":"29","author":"Cohen","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2020.107068_bb0040","doi-asserted-by":"crossref","first-page":"k3625","DOI":"10.1136\/bmj.k3625","article-title":"Valproate, women, and exceptional circumstances","volume":"362","author":"Angus-Leppan","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.yebeh.2020.107068_bb0045","doi-asserted-by":"crossref","first-page":"k724","DOI":"10.1136\/bmj.k724","article-title":"Do the benefits of folic acid fortification outweigh the risk of masking vitamin B12 deficiency? Yes","volume":"360","author":"Mills","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.yebeh.2020.107068_bb0050","first-page":"k724","article-title":"Do the benefits of folic acid fortification outweigh the risk of masking vitamin B12 deficiency? No","volume":"360","author":"Reynolds","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.yebeh.2020.107068_bb0055","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.3945\/ajcn.2009.27514","article-title":"Metabolic evidence of vitamin B12 deficiency, including high homocysteine and methylmalonic acid and low holotranscobalamin, is more pronounced in older adults with elevated plasma folate","volume":"90","author":"Miller","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.yebeh.2020.107068_bb0060","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mam.2016.11.004","article-title":"Interaction between excess folate and low vitamin B12 status","volume":"53","author":"Paul","year":"2019","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.yebeh.2020.107068_bb0065","series-title":"Folate in health and disease","first-page":"133","article-title":"Folate status and birth defect risk: epidemiological perspective","author":"Hobbs","year":"2010"},{"key":"10.1016\/j.yebeh.2020.107068_bb0070","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1212\/WNL.0000000000000030","article-title":"In utero exposure to levetiracetam vs valproate: development and language at 3 years of age","volume":"82","author":"Shallcross","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2020.107068_bb0075","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.seizure.2016.10.006","article-title":"Foetal antiepileptic drug exposure and cognitive outcomes","volume":"44","author":"Bromley","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2020.107068_bb0080","doi-asserted-by":"crossref","first-page":"e811","DOI":"10.1212\/WNL.0000000000006073","article-title":"Verbal abilities in children of mothers with epilepsy: association to maternal folate status","volume":"91","author":"Husebye","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2020.107068_bb0085","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/jama.2012.155925","article-title":"Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children","volume":"309","author":"Suren","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.yebeh.2020.107068_bb0090","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1001\/jamaneurol.2017.3897","article-title":"Association of folic acid supplementation during pregnancy with the risk of autistic traits in children exposed to antiepileptic drugs in utero","volume":"75","author":"Bjork","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.yebeh.2020.107068_bb0095","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1001\/jama.2011.1433","article-title":"Folic acid supplements in pregnancy and severe language delay in children","volume":"306","author":"Roth","year":"2011","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.yebeh.2020.107068_bb0100","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/jamapsychiatry.2018.3901","article-title":"Association of maternal prenatal vitamin use with risk for autism spectrum disorder recurrence in young siblings","volume":"76","author":"Schmidt","year":"2019","journal-title":"JAMA Psychiat"},{"key":"10.1016\/j.yebeh.2020.107068_bb0105","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/brain\/91.2.197","article-title":"Mental effects of anticonvulsants, and folic acid metabolism","volume":"91","author":"Reynolds","year":"1968","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2020.107068_bb0110","series-title":"Handbook of Clinical Neurology","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/B978-0-7020-4087-0.00061-9","article-title":"The neurology of folic acid deficiency","volume":"120","author":"Reynolds","year":"2014"},{"key":"10.1016\/j.yebeh.2020.107068_bb0115","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1136\/jnnp.45.1.55","article-title":"A comparison of phenytoin and valproate in previously untreated adult epileptic patients","volume":"45","author":"Turnbull","year":"1982","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.yebeh.2020.107068_bb0120","series-title":"Advances in epileptology: X11th Epilepsy International Symposium","first-page":"671","article-title":"Anticonvulsant \u2013 folate interactions","author":"Smith","year":"1981"},{"key":"10.1016\/j.yebeh.2020.107068_bb0125","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1001\/archneur.1973.00490190036003","article-title":"Folate metabolism and the anticonvulsant efficacy of phenobarbital","volume":"28","author":"Smith","year":"1973","journal-title":"Arch Neurol"},{"key":"10.1016\/j.yebeh.2020.107068_bb0130","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/epi.14078","article-title":"Adverse placental effects of valproic acid: studies in perfused human placentas","volume":"59","author":"Rubinchik-Stern","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107068_bb0135","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/bdra.23277","article-title":"Novel mechanism for valproate-induced teratogenicity","volume":"100","author":"Fathe","year":"2014","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.yebeh.2020.107068_bb0140","first-page":"17","article-title":"Alteration of embryonic folate metabolism by valproic acid during organogenesis: implications for mechanism of teratogenesis","volume":"42","author":"Wegner","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2020.107068_bb0145","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S1474-4422(06)70598-1","article-title":"Vitamin B12, folic acid and the nervous system","volume":"5","author":"Reynolds","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2020.107068_bb0150","series-title":"Folate in health and disease","first-page":"49","article-title":"Folate biochemical pathways and their regulation","author":"Stover","year":"2010"},{"key":"10.1016\/j.yebeh.2020.107068_bb0155","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-004936","article-title":"Increased homocysteine levels in valproate-treated patients with epilepsy: a meta-analysis","volume":"4","author":"Ni","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.yebeh.2020.107068_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125656","article-title":"Effects of antiepileptic drug monotherapy on one-carbon metabolism and DNA methylation in patients with epilepsy","volume":"10","author":"Ni","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.yebeh.2020.107068_bb0165","doi-asserted-by":"crossref","first-page":"458","DOI":"10.4161\/epi.19617","article-title":"Prenatal epileptic exposure associates with neonatal DNA methylation differences","volume":"7","author":"Smith","year":"2012","journal-title":"Epigenetics"},{"key":"10.1016\/j.yebeh.2020.107068_bb0170","doi-asserted-by":"crossref","first-page":"17.1","DOI":"10.1146\/annurev-nutr-071714-034235","article-title":"Genetic risk factors for folate-responsive neural tube defects","volume":"37","author":"Molloy","year":"2017","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.yebeh.2020.107068_bb0175","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1002\/ajmg.a.31914","article-title":"Fetal anticonvulsant syndromes and polymorphisms in MTHFR, MTR, and MTRR","volume":"143A","author":"Dean","year":"2007","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.yebeh.2020.107068_bb0180","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0387-7604(02)00004-9","article-title":"The C677T mutation in the methylene tetrahydrofolate reductase gene contributes to hyperhomocysteinemia in patients taking anticonvulsants","volume":"24","author":"Ono","year":"2002","journal-title":"Brain Dev"},{"key":"10.1016\/j.yebeh.2020.107068_bb0185","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.yebeh.2013.09.034","article-title":"Role of plasma-homocysteine levels and MTHFR polymorphisms on IQ scores in children and young adults with epilepsy treated with antiepileptic drugs","volume":"29","author":"Rosi","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2020.107068_bb0190","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1515\/cclm-2012-0580","article-title":"Homocysteine plasma levels in patients treated with antiepileptic drugs depend on folate and vitamin B12 serum levels, but not on genetic variants of homocysteine metabolism","volume":"51","author":"Semmler","year":"2013","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.yebeh.2020.107068_bb0195","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1136\/practneurol-2018-001955","article-title":"Valproate and childbearing potential: new regulations","volume":"18","author":"Sisodiya","year":"2018","journal-title":"Pract Neurol"},{"key":"10.1016\/j.yebeh.2020.107068_bb0200","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.celrep.2017.10.072","article-title":"Partitioning of one-carbon units in folate and methionine metabolism is essential for neural tube closure","volume":"21","author":"Leung","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.yebeh.2020.107068_bb0205","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1056\/NEJM197803232981203","article-title":"Racial patterns in pernicious anemia. Early age at onset and increased frequency of intrinsic-factor antibody in black women","volume":"298","author":"Carmel","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2020.107068_bb0210","article-title":"Vitamin B12 deficiency","volume":"3","author":"Green","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"10.1016\/j.yebeh.2020.107068_bb0215","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s10654-013-9849-0","article-title":"Periconceptional folic acid associated with an increased risk of oral clefts relative to non-folate related malformations in the Northern Netherlands: a population based case-control study","volume":"28","author":"Rozendaal","year":"2013","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.yebeh.2020.107068_bb0220","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/ppe.12414","article-title":"Maternal multivitamin intake, plasma folate and vitamin B(12) levels and autism spectrum disorder risk in offspring","volume":"32","author":"Raghavan","year":"2018","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"5","key":"10.1016\/j.yebeh.2020.107068_bb0225","first-page":"888","article-title":"High dietary folate in pregnant mice leads to pseudo-MTHFR deficiency and altered methyl metabolism, with embryonic growth delay and short-term memory impairment in offspring","volume":"26","author":"Bahous","year":"2017","journal-title":"Hum Mol Genet"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550502030247X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550502030247X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:31:52Z","timestamp":1761503512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152550502030247X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":45,"alternative-id":["S152550502030247X"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.107068","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valproate and folate: Congenital and developmental risks","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.107068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107068"}}